$131 Million is the total value of Petix & Botte Co's 68 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SRE | SEMPRA | $893,000 | -0.2% | 5,958 | 0.0% | 0.68% | +3.2% | |
IWF | ISHARES TRrus 1000 grw etf | $792,000 | -3.8% | 3,764 | 0.0% | 0.60% | -0.5% | |
MGV | VANGUARD WORLD FDmega cap val etf | $408,000 | -6.6% | 4,542 | 0.0% | 0.31% | -3.4% | |
PWR | QUANTA SVCS INC | $366,000 | +1.7% | 2,872 | 0.0% | 0.28% | +5.3% | |
MDY | SPDR S&P MIDCAP 400 ETF TRutser1 s&pdcrp | $365,000 | -2.7% | 908 | 0.0% | 0.28% | +0.7% | |
VOT | VANGUARD INDEX FDSmcap gr idxvip | $256,000 | -2.7% | 1,499 | 0.0% | 0.20% | +0.5% | |
PFE | PFIZER INC | $226,000 | -16.6% | 5,164 | 0.0% | 0.17% | -14.0% | |
IVW | ISHARES TRs&p 500 grwt etf | $213,000 | -4.1% | 3,684 | 0.0% | 0.16% | -0.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-10-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ISHARES TR | 18 | Q2 2024 | 9.2% |
VANGUARD SCOTTSDALE FDS | 18 | Q2 2024 | 9.5% |
VANGUARD BD INDEX FDS | 18 | Q2 2024 | 9.5% |
ISHARES TR | 18 | Q2 2024 | 7.7% |
FIRST TR VALUE LINE DIVID IN | 18 | Q2 2024 | 7.1% |
FIRST TR EXCHANGE-TRADED FD | 18 | Q2 2024 | 7.5% |
ISHARES TR | 18 | Q2 2024 | 5.1% |
VANGUARD INDEX FDS | 18 | Q2 2024 | 5.2% |
FIRST TR EXCHANGE-TRADED FD | 18 | Q2 2024 | 4.2% |
VANGUARD INDEX FDS | 18 | Q2 2024 | 4.3% |
View Petix & Botte Co's complete holdings history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-28 |
13F-HR | 2024-08-13 |
13F-HR | 2024-05-06 |
13F-HR | 2024-02-06 |
13F-HR | 2023-11-15 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2022-10-14 |
13F-HR | 2022-08-04 |
13F-HR | 2022-04-26 |
View Petix & Botte Co's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.